Does RISANKIZUMAB Cause Inflammatory bowel disease? 32 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Inflammatory bowel disease have been filed in association with RISANKIZUMAB (Skyrizi). This represents 1.2% of all adverse event reports for RISANKIZUMAB.
32
Reports of Inflammatory bowel disease with RISANKIZUMAB
1.2%
of all RISANKIZUMAB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Inflammatory bowel disease From RISANKIZUMAB?
Of the 32 reports, 1 (3.1%) resulted in death, 3 (9.4%) required hospitalization.
Is Inflammatory bowel disease Listed in the Official Label?
Yes, Inflammatory bowel disease is listed as a known adverse reaction in the official FDA drug label for RISANKIZUMAB.
What Other Side Effects Does RISANKIZUMAB Cause?
Product storage error (396)
Drug ineffective (206)
Psoriasis (138)
Crohn's disease (103)
Arthralgia (100)
Off label use (100)
Product temperature excursion issue (88)
Diarrhoea (72)
Fatigue (70)
Rash (64)
What Other Drugs Cause Inflammatory bowel disease?
ISOTRETINOIN (692)
ADALIMUMAB (517)
INFLIXIMAB (444)
SECUKINUMAB (440)
VEDOLIZUMAB (271)
ACCUTANE (223)
METHOTREXATE (199)
USTEKINUMAB (166)
TACROLIMUS (160)
ETANERCEPT (135)
Which RISANKIZUMAB Alternatives Have Lower Inflammatory bowel disease Risk?
RISANKIZUMAB vs RISANKIZUMAB-RZAA
RISANKIZUMAB vs RISDIPLAM
RISANKIZUMAB vs RISEDRONATE
RISANKIZUMAB vs RISEDRONIC ACID
RISANKIZUMAB vs RISPERDAL